Wedbush initiated coverage of MannKind (MNKD) with an Outperform rating and $11 price target
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MNKD:
- JMP Securities healthcare analysts hold an analyst/industry conference call
- MannKind Announces Upcoming Retirement of Lauren Sabella
- MannKind initiated with an Overweight at Wells Fargo
- RBC upgrades MannKind on royalty revenue, orphan lung pipeline
- MannKind upgraded to Outperform from Sector Perform at RBC Capital